Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Braun, Donald P ^a   Gupta, Digant ^a   Grutsch, James F ^a   Staren, Edgar D ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANOREXIA; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREDICTION; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SCORING SYSTEM; SOCIAL STATUS; AGED; COLORECTAL TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; SICKNESS IMPACT PROFILE; SURVIVAL; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 79961017055     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-62     Document Type: Article

References (28)

1. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997, 33:1025-1030. 10.1016/S0959-8049(97)00049-X, 9376182.
2. Collette L, van Andel G, Bottomley A, Oosterhof GO, Albrecht W, de Reijke TM, Fossà SD. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 2004, 22:3877-3885. 10.1200/JCO.2004.07.089, 15459209.
3. Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997, 6:151-158.
4. Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D. Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004, 13:1209-1216.
5. Efficace F, Biganzoli L, Piccart M, Coens C, Van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A, . EORTC-BCG-IDBBC-NDDG Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 2004, 40:1021-1030. 10.1016/j.ejca.2004.01.014, 15093577, EORTC-BCG-IDBBC-NDDG.
6. Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000, 55:19-25.
7. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002, 38:1351-1357. 10.1016/S0959-8049(02)00098-9, 12091066.
8. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001, 31:233-240. 10.1016/S0169-5002(00)00179-3, 11165402.
9. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A, . EORTC Clinical Groups Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009, 10:865-871. 10.1016/S1470-2045(09)70200-1, 19695956, EORTC Clinical Groups.
10. Roychowdhury DF, Hayden A, Liepa AM. Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003, 21:673-678. 10.1200/JCO.2003.04.166, 12586805.
11. Meyer F, Fortin A, Gelinas M, Nabid A, Brochet F, Tetu B, Bairati I. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 2009, 27:2970-2976. 10.1200/JCO.2008.20.0295, 19451440.
12. Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmström P, Valvere V, Tennvall L, Blomqvist C. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003, 39:1370-1376. 10.1016/S0959-8049(02)00775-X, 12826039.
13. Djarv T, Metcalfe C, Avery KN, Lagergren P, Blazeby JM. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol 2010, 28:1666-1670. 10.1200/JCO.2009.23.5143, 20194863.
14. Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Kuik DJ, de Bree R, Doornaert P, Langendijk JA, Leemans RC. Quality of life as predictor of survival: a prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer. Radiother Oncol 2010, 97:258-262. 10.1016/j.radonc.2010.02.005, 20189668.
15. Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001, 49:227-230. 10.1136/gut.49.2.227, 1728414, 11454799.
16. Camilleri-Brennan J, Steele RJ. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 2001, 88:1617-1622. 10.1046/j.0007-1323.2001.01933.x, 11736975.
17. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996, 14:171-175.
18. Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F. Chronotherapy Group of the European Organisation for Research and Treatment of Cancer: Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2008, 20;26:2020-2026.
19. Lis CG, Gupta D, Granick J, Grutsch JF. Can patient satisfaction with quality of life predict survival in advanced colorectal cancer?. Support Care Cancer 2006, 14:1104-1110. 10.1007/s00520-006-0100-3, 16819630.
20. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16:139-144.
21. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376. 10.1093/jnci/85.5.365, 8433390.
22. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997, 50:441-450. 10.1016/S0895-4356(96)00428-3, 9179103.
23. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995, 13:1249-1254.
24. Van Steen K, Curran D, Kramer J, Molenberghs G, Van Vreckem A, Bottomley A, et al. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med 2002, 21:3865-3884. 10.1002/sim.1358, 12483772.
25. O'Brien, Robert M. A Caution Regarding Rules of Thumb for Variance Inflation Factors. Quality & Quantity 2007, 41:673-690. 10.1007/s11135-006-9018-6, 21815266.
26. Besley D, Kuh E, Welsch R. Regression Diagnostics: Identifying Influential Data and Sources of Multicollinearity 2004, Wiley, New York.
27. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992, 11:2093-2109. 10.1002/sim.4780111607, 1293671.
28. Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schoffski P, Schmoll H, Van Cutsem E, Köhne CH. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?. Eur J Cancer 2006, 42:42-49. 10.1016/j.ejca.2005.07.025, 16298522.